ANNEXON, INC. Other Current Assets
ANNEXON, INC. (ANNX) had Other Current Assets of $23.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Balance Sheet › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-08-12
- 2024-03-31: Other Assets, Current $23.00K.
- 2023-12-31: Other Assets, Current $63.00K.
- 2023-09-30: Other Assets, Current $13.00K.
- 2023-06-30: Other Assets, Current $167.00K.
| Period end | Other Assets, Current |
|---|---|
| 2024-03-31 | $23.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $63.00K 10-Q · filed 2024-08-12 |
| 2023-09-30 | $13.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $167.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $165.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $203.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $57.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $37.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $134.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $463.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $231.00K 10-Q · filed 2021-11-09 |
| 2021-03-31 | $38.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $3.00K 10-Q · filed 2021-11-09 |
| 2020-09-30 | $4.00K 10-Q · filed 2020-11-16 |
| 2019-12-31 | $79.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |